1Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht Ⅲ Consensus Report. Gut, 2007, 56 (6): 772-781. 被引量：1
2Laheij R J, Rossum LG, Jansen JB, et al. Evaluation of treatment regimens to cure Helicobacter pylori infection -- a meta-analysis. Aliment Pharmcol Ther, 1999, 13 (7): 857-864. 被引量：1
3Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther, 2003, 17 (5): 719-726. 被引量：1
4Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med, 2007, 146 (8): 556-563. 被引量：1
5Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2000, 14 (6): 715- 718. 被引量：1
6De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis, 2001, 33 (8): 676-679. 被引量：1
7Calvet X, Garcia N, Lopez T, et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther, 2000, 14 (5): 603-609. 被引量：1
8Hassan C, De Francesco V, Zullo A, et al. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmaeotherapy. Aliment Pharmacol Ther, 2003, 18 (6): 641-646. 被引量：1
9Gomollon F, Santolaria S, Sicilia B, et al. Helicobacter pylori resistance to metronidazole and clarythromicin: descriptive analysis 1997-2000. Med Clin (Barc), 2004, 123 (13): 481-485. 被引量：1
